FDA Drug Application (021153) for NEXIUM by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number021153
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNEXIUM
Active IngredientESOMEPRAZOLE MAGNESIUM



Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.